Study genetics in people with spontaneous artery tears
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks for genetic (inherited) reasons some people develop SCAD, a sudden tear in a heart artery. It compares people with SCAD to people without it and may help doctors recognize risk and causes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a coronary angiography (a special heart artery X-ray) done
- If you are a SCAD case: you were suspected of having SCAD based on your clinical report
- If you are a control (comparison group): you had angiography for stable angina and no or mild plaque disease
- Control group participants must be age 50 or older
- You must be willing to provide consent and a blood sample (for genetics testing)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic (inherited) causes of spontaneous coronary artery dissection (SCAD) in families. It may help researchers understand why SCAD happens and how it could be prevented or identified earlier in others.
This study looks at people admitted with a recent heart event (STEMI, NSTEMI, or unstable angina) and who were found to have SCAD on a heart scan. It may help doctors better understand and manage SCAD after these urgent events.
This study collects information from people diagnosed with spontaneous coronary artery dissection (SCAD) in the last 10 years. It aims to learn more about this rare heart condition to improve future care.
This study looks at how the body’s automatic “fight-or-flight” nerve system may relate to spontaneous coronary artery dissection (SCAD). If you have a SCAD history, your results may help researchers understand the condition better; if you’re a healthy control, your data are compared to SCAD patients.
This is a national Swiss registry that collects information about people who have been newly diagnosed with spontaneous coronary artery dissection (SCAD) or diagnosed within the last 5 years. Your participation can help doctors better understand SCAD and improve future care.
This trial studies whether taking a beta-blocker and an antiplatelet (blood thinner) helps people recover after spontaneous coronary artery dissection (SCAD). It randomizes participants to treatment combinations, aiming to see which approach works best after an event affecting heart blood flow.
Hear when a new Spontaneous Coronary Artery Dissection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.